JP5376785B2 - 医薬組成物 - Google Patents

医薬組成物 Download PDF

Info

Publication number
JP5376785B2
JP5376785B2 JP2007256016A JP2007256016A JP5376785B2 JP 5376785 B2 JP5376785 B2 JP 5376785B2 JP 2007256016 A JP2007256016 A JP 2007256016A JP 2007256016 A JP2007256016 A JP 2007256016A JP 5376785 B2 JP5376785 B2 JP 5376785B2
Authority
JP
Japan
Prior art keywords
compound
general formula
nerve
composition
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2007256016A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009084207A (ja
Inventor
学 野崎
茂樹 澤村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kobayashi Pharmaceutical Co Ltd
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Priority to JP2007256016A priority Critical patent/JP5376785B2/ja
Priority to PCT/JP2008/067693 priority patent/WO2009041700A1/fr
Publication of JP2009084207A publication Critical patent/JP2009084207A/ja
Application granted granted Critical
Publication of JP5376785B2 publication Critical patent/JP5376785B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2007256016A 2007-09-28 2007-09-28 医薬組成物 Expired - Fee Related JP5376785B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2007256016A JP5376785B2 (ja) 2007-09-28 2007-09-28 医薬組成物
PCT/JP2008/067693 WO2009041700A1 (fr) 2007-09-28 2008-09-29 Composition pharmaceutique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007256016A JP5376785B2 (ja) 2007-09-28 2007-09-28 医薬組成物

Publications (2)

Publication Number Publication Date
JP2009084207A JP2009084207A (ja) 2009-04-23
JP5376785B2 true JP5376785B2 (ja) 2013-12-25

Family

ID=40511578

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007256016A Expired - Fee Related JP5376785B2 (ja) 2007-09-28 2007-09-28 医薬組成物

Country Status (2)

Country Link
JP (1) JP5376785B2 (fr)
WO (1) WO2009041700A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5376786B2 (ja) * 2007-09-28 2013-12-25 小林製薬株式会社 神経細胞賦活組成物
CN102579584A (zh) * 2011-01-06 2012-07-18 赵能 一种疏通经络治理面瘫的保健丸

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008221A (en) * 1996-11-06 1999-12-28 Bristol-Myers Squibb Company Method for treating Alzheimer's disease with folic acid
AU3768800A (en) * 1999-03-26 2000-10-16 Emil H. Franssen Treatment of brain changes with myelin protective agents
JP5376786B2 (ja) * 2007-09-28 2013-12-25 小林製薬株式会社 神経細胞賦活組成物

Also Published As

Publication number Publication date
JP2009084207A (ja) 2009-04-23
WO2009041700A1 (fr) 2009-04-02

Similar Documents

Publication Publication Date Title
TW200838545A (en) Therapeutic agent for painful disease
US20060052455A1 (en) Composition for preventing treating the xepression of clinical symptom in disease caused by mitochondrial dysfunction
JP5376785B2 (ja) 医薬組成物
KR101342716B1 (ko) 항-혈소판 약물, 영양 및 비타민 보충물로서의 아세틸화된아미노산
JP5376786B2 (ja) 神経細胞賦活組成物
AU2922389A (en) Improving toxicity profiles in chemotherapy
JP5366386B2 (ja) 神経細胞賦活及び神経伸長促進用組成物
JPH0475205B2 (fr)
TWI236907B (en) An agent for improving hypoalbuminaemia
JP2588191B2 (ja) 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤
WO2014129513A1 (fr) Agent de prévention ou de traitement de la colite ulcéreuse et nouveau dérivé de fullerène
CA3157656A1 (fr) Utilisation de nictotinamide mononucleotide (nmn) pour la prevention et/ou le traitement de la polyarthrite rhumatoide et compositions correspondantes
JP3450399B2 (ja) 血管新生阻害剤
KR20040010666A (ko) ２ 형 인슐린 내성 당뇨병 환자의 치료를 위한 비오틴과회합된 아세틸 ｌ-카르니틴의 용도
JPH0826982A (ja) 骨粗鬆症予防・治療剤
CN112516121B (zh) 包含牛磺酸和别嘌醇的组合物及其医药用途
WO2010098475A1 (fr) Agent de prévention et de traitement de troubles de la nutrition
WO2008015763A1 (fr) Formulation médicamenteuse contenant un médicament fibrate et procédé pour la produire
JP2004123558A (ja) 片頭痛の予防、治療剤
JP2018504439A (ja) 粘膜炎の治療のための組成物及び方法
JPH072867A (ja) ビオチンアミド誘導体の製造方法及び、それらを含有する糖尿病及び糖尿病合併症の治療剤
US4701467A (en) Tolrestat as anti-hypertensive agent
WO2020262317A1 (fr) Médicament pour le traitement et la prévention de la démence
JPH0440328B2 (fr)
JP2013014590A (ja) 消化管及び腎臓の萎縮抑制剤

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100908

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121127

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130128

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130402

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130603

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130903

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130924

R150 Certificate of patent or registration of utility model

Ref document number: 5376785

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees